CATALOG PRODUCT FINDER
Chelate Peptides (DOTA)

DOTA is used as a complexing agent in medical applications as contrast agents and cancer treatments. Therefore, DOTA is linked to molecules that have affinity for various structures (e.g. somatostatin receptors in neuroendocrine tumors). The resulting compounds can be bound to radionuclides and are used with a number of radioisotopes in cancer therapy and diagnosis (for example in positron emission tomography). The offered DOTA peptides are for research use only!
For customized DOTA peptides please visit our custom peptide synthesis page.
Item 1 thru 3 of 3 | Pages: [1] | |
Precursor for radiolabelled DOTA-NOC and ligand for somatostatin receptors. For research use only!

Precursor for radiolabelled DOTA-TATE and ligand for somatostatin receptors. For research use only!

Precursor for radiolabelled DOTA-TOC and ligand for somatostatin receptors. For research use only!

Item 1 thru 3 of 3 | Pages: [1] | |
News
NEW: SARS-COV-2 B.1.1.7(UK) & HCoV NCAP PepMixesTM
(Jan 2021)
Read more
13 NEW Immunopeptidomics Kits
References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more
Infectious diseases beyond COVID-19
JPT's peptide formats in the literature
(Oct 2020)
Read more
SARS COV-2 Mass Spec Reference Kit Released!:
SARS-CoV-2 SpikeMix for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more